PIMCO Municipal Income Fund III PMX
6.68 0.00 (+0.00%)
At closeAug 1, 2025, 4:00 PM EDT
6.61 Day range 6.68
7.02 52-week range 8.52
- Market cap
- 241.68M
- Revenue (ttm)
- 21.88M
- Profit margin
- 51.66%
- EPS (ttm)
- 0.14
- Shares out
- 33.43M
- P/E ratio
- 51.64
- Dividend
- 0.40 (5.45%)
- Ex-dividend date
- Dec 11, 2024
- Volume
- 79.89K
- Avg volume
- 108.26K
- Open
- 6.62
- Previous close
- 6.68
- Day's range
- 6.61 – 6.68
- 52-week range
- 7.02 – 8.52
No chart data for this range yet.
Key statistics
- Enterprise value
- 427.93M
- PEG ratio
- 0.00
- Price / sales
- 11.05
- Price / book
- 0.89
- Dividend yield
- 5.45%
- Payout ratio
- 282.86%
- Revenue growth
- -3.20%
- Free cash flow
- 11.76M
- Total cash
- 465.00K
- Total debt
- 184.20M
- Return on equity
- 3.22%
- Short % of float
- 0.00%
- 50-day average
- 7.85
- 200-day average
- 7.76
Next earnings
Consensus EPS estimate 0.00.
About PIMCO Municipal Income Fund III
PIMCO Municipal Income Fund III is a closed-ended fixed income mutual fund launched and managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in in municipal bonds that pay interest that is exempt from federal income tax. PIMCO Municipal Income Fund III was formed on October 31, 2002 and is domiciled in United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
Rockford Fosgate® Introduces PMX-6BB Hidden Digital Media Receiver for Seamless Marine Audio Control 
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX 
ProAm Reports Results of Terrane Structural Review and Identifies District-Scale Targets at Golden Ridge 
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial 
Spectral Medical Announces PMA Submission to U.S. FDA for PMX 
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R 
Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock 
PIMCO Closed-End Funds Declare Monthly Common Share Distributions 
PMX: Municipal CEF With Turnaround Potential 
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Your note
Sign in to keep a note on PMX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COGAN SARAH E | Director | Purchase | Jan 23, 2024 | 2,567 |
| RAPPAPORT ALAN H | Director | Purchase | Nov 13, 2023 | 4,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Hennion & Walsh Asset Management, Inc. | 2.40% | 804,465 | 5.82M | Sep 29, 2024 |
| Morgan Stanley | 2.32% | 775,585 | 5.61M | Sep 29, 2024 |
| Advisors Asset Management, Inc. | 1.92% | 641,135 | 4.64M | Sep 29, 2024 |
| Guggenheim Capital, LLC | 1.91% | 639,993 | 4.63M | Sep 29, 2024 |
| Fiera Capital Corporation | 1.26% | 422,208 | 3.05M | Sep 29, 2024 |
| Gill Capital Partners, LLC | 1.25% | 419,344 | 3.03M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HC Capital Trust-The Intermediate Term Municipal Bond Portfolio | 1.00% | 333,198 | 2.41M | Sep 29, 2024 |
| VanEck ETF Trust-VanEck CEF Muni Income ETF | 0.50% | 167,503 | 1.21M | Oct 30, 2024 |
| Aspiriant Risk Managed Municipal Bond Fd | 0.05% | 18,314 | 132.41K | Sep 29, 2024 |